References
- Smith R M, Curnutte J T. Molecular basis of chronic granulomatous disease. Blood 1991; 77: 673–686
- Baechner R L. Disorders of granulocyte function. Blood diseases of infancy and childhood, D R Miller. C.V. Mosby Company. 1990; 549–577
- Gallin J I, Malech H L. Update on chronic granulomatous diseases in childhood. JAMA 1990; 263: 1533–1537
- Clark R A. The human neutrophil respiratory burst oxidase. J Infect Dis 1990; 161: 1140–1147
- Segal A W. The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. J Clin Invest 1989; 83: 1785–1793
- Ezekowitz R A B, Orkin S H, Newburger P E. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J Clin Invest 1987; 80: 1009–1016
- Sechler J M G, Malech H L, White J, Gallin J I. Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci USA 1988; 85: 4874–4878
- Ezekowitz R A B, Phil D, Dinauer M C, Jaffe H S, Orkin S H, Newburger P E. Partial correlation of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 1988; 319: 146–151
- Gallin J I, Malech H L, Weening R S, Curnutte J T, Quie P G, Jaffe H S, Ezekowitz R A B. (“The international chronic granulomatous disease cooperative study group”). A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991; 324: 509–516
- Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combined centrifugation and sedimentation at 1 × g. Scand J Clin Lab Invest, suppl 1968; 97: 77–89
- Follin P, Dahlgren C. Altered O–2/H2O2 production ratio by in vitro and in vivo primed human neutrophils. Biochem Biophys Res Commun 1990; 167: 970–976
- Follin P, Dahlgren C. Phagocytosis by lipopolysaccharide primed human neutrophils is associated with an increased extracellular release of reactive oxygen metabolites. Inflammation 1992; 16: 83–91
- Metcalf J A, Gallin J I, Nauseef W M, Root R K. Laboratory manual of neutrophil function. Raven Press, New York 1986
- Holmes B, Page A R, Good R A. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest 1967; 46: 1422–1432
- Quie P G, White J G, Holmes B, Good R A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease in childhood. J Clin Invest 1967; 46: 668–679
- Segal A W. Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 1987; 326: 88–91
- Teahan C, Rowe P, Parker P, Totty N, Segal A W. The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245. Nature 1987; 327: 720–721
- Nunoi H, Rotrosen D, Gallin J I, Malech H L. Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science 1988; 242: 1298–1301
- Volpp B D, Nauseef W M, Clark R A. Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 1988; 242: 1295–1297
- Baron S, Tyring S K, Fleischman W R, Jr, Coppenhaver D H, Niesel D W, Klimpel G R, Stanton G J, Hughes T. The interferons. Mechanisms of action and clinical applications. JAMA 1991; 266: 1375–1383